Molecular methods for ehrlichiosis and Lyme disease

Clinics in Laboratory Medicine

Volumn 23, Issue 4, 2003, Pages 867-884

  Dumler, J Stephen ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM DETECTION; BORRELIA BURGDORFERI; BORRELIA INFECTION; CEREBROSPINAL FLUID ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DISEASE CARRIER; EHRLICHIA CHAFFEENSIS; EHRLICHIOSIS; ERYTHEMA CHRONICUM MIGRANS; GENE TARGETING; HUMAN; LABORATORY DIAGNOSIS; LYME DISEASE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REVIEW; SERODIAGNOSIS; SEROPREVALENCE; SKIN BIOPSY; URINALYSIS;

EID: 0346341057     PISSN: 02722712     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0272-2712(03)00080-5     Document Type: Review

References (104)

1. Steere AC, Malawista SE, Snydman DR, Shope RE, Andiman WA, Ross MR, et al. Lyme arthritis: an epidemic of oligoarticular arthritis in children and adults in three Connecticut communities. Arthritis Rheum 1977;20:7-17.
2. Steere AC. Lyme disease. N Engl J Med 2001;345:115-25.
3. Smith RP, Schoen RT, Rahn DW, Sikand VK, Nowakowski J, Parenti DL, et al. Clinical characteristics and treatment outcome of early Lyme disease in patients with microbiologically confirmed erythema migrans. Ann Intern Med 2002;136:421-8.
4. Klempner MS, Hu LT, Evans J, Schmid CH, Johnson GM, Trevino RP, et al. Two controlled trials of antibiotic treatment in patients with persistent symptoms and a history of Lyme disease. N Engl J Med 2001;345:85-92.
5. Aguero-Rosenfeld ME, Nowakowski J, Bittker S, Cooper D, Nadelman RB, Wormser GP. Evolution of the serologic response to Borrelia burgdorferi in treated patients with culture-confirmed erythema migrans. J Clin Microbiol 1996;34:1-9.
6. Burgdorfer W, Barbour AG, Hayes SF, Benach JL, Grunwaldt E, Davis JP. Lyme disease-a tick-borne spirochetosis? Science 1982;216:1317-9.
7. Wormser GP, Bittker S, Cooper D, Nowakowski J, Nadelman RB, Pavia C. Yield of large-volume blood cultures in patients with early Lyme disease. J Infect Dis 2001;184:1070-2.
8. Fraser CM, Casjens S, Huang WM, Sutton GG, Clayton R, Lathigra R, et al. Genomic sequence of a Lyme disease spirochaete, Borrelia burgdorferi. Nature 1997;390:580-6.
9. Ohnishi J, Piesman J, de Silva AM. Antigenic and genetic heterogeneity of Borrelia burgdorferi populations transmitted by ticks. Proc Natl Acad Sci USA 2001;98:670-5.
10. Hefty PS, Jolliff SE, Caimano MJ, Wikel SK, Akins DR. Changes in temporal and spatial patterns of outer surface lipoprotein expression generate population heterogeneity and antigenic diversity in the Lyme disease spirochete, Borrelia burgdorferi. Infect Immun 2002;70:3468-78.
11. Anguita J, Thomas V, Samanta S, Persinski R, Hernanz C, Barthold SW, et al. Borrelia burgdorferi-induced inflammation facilitates spirochete adaptation and variable major protein-like sequence locus recombination. J Immun 2001;167:3383-90.
12. McDowell JV, Sung SY, Hu LT, Marconi RT. Evidence that the variable regions of the central domain of VlsE are antigenic during infection with lyme disease spirochetes. Infect Immun 2002;70:4196-203.
13. Stevenson B, El-Hage N, Hines MA, Miller JC, Babb K. Differential binding of host complement inhibitor factor H by Borrelia burgdorferi erp surface proteins: a possible mechanism underlying the expansive host range of Lyme disease spirochetes. Infect Immun 2002;70:491-7.
14. Lebech A-M, Clemmensen O, Hansen K. Comparison of in vitro culture, immunohistochemical staining and PCR for detection of Borrelia burgdorferi in tissue from experimentally infected animals. J Clin Microbiol 1995;33:2328-33.
15. Melchers W, Meis J, Rosa P, Claas E, Nohlmans L, Koopman R, et al. Amplification of Borrelia burgdorferi DNA in skin biopsies from patients with Lyme disease. J Clin Microbiol 1991;29:2401-6.
16. Goodman JL, Jurkovich P, Kramber JM, Johnson RC. Molecular detection of persistent Borrelia burgdorferi in the urine of patients with active Lyme disease. Infect Immun 1991;59:269-78.
17. Karch H, Huppertz H-I, Bohme M, Schmidt H, Wiebecke D, Schwarzkopf. Demonstration of Borrelia burgdorferi DNA in urine samples from healthy humans whose sera contain B burgdorferi-specific antibodies. J Clin Microbiol 1994;32:2312-4.
18. Schwartz I, Wormser GP, Schwartz JJ, Cooper D, Weissensee P, Gazumyan A, et al. Diagnosis of early Lyme disease by polymerase chain reaction amplification and culture of skin biopsies from erythema migrans lesions. J Clin Microbiol 1992;30:3082-8.
19. Keller TL, Halperin JJ, Whitman M. PCR detection of Borrelia burgdorferi DNA in cerebrospinal fluid of Lyme neuroborreliosis patients. Neurology 1992;42:32-42.
20. Luft BJ, Steinman CR, Neimark HC, Muralidhar B, Rush T, Finkel MF, et al. Invasion of the central nervous system by Borrelia burgdorferi in acute disseminated infection. JAMA 1992;267:1364-7.
21. Goodman JL, Bradley BA, Ross AE, Goellner P, Lagus A, Vitale B, et al. Bloodstream invasion in early Lyme disease: results from a prospective, controlled, blinded study using polymerase chain reaction. Am J Med 1995;99:6-12.
22. Nocton JJ, Dressler F, Rutledge BJ, Rys PN, Persing DH, Steere AC. Detection of Borrelia burgdorferi DNA by polymerase chain reaction in synovial fluid from patients with Lyme arthritis. N Engl J Med 1994;330:229-34.
23. Persing DH, Telford SR III, Spielman A, Barthold SW. Detection of Borrelia burgdorferi infection in Ixodes dammini ticks with the polymerase chain reaction. J Clin Microbiol 1990;28:566-72.
24. Nowakowski J, Schwartz I, Liveris D, Wang G, Aguero-Rosenfeld ME, Girao G, et al. Laboratory diagnostic techniques for patients with early Lyme disease associated with erythema migrans: a comparison of different techniques. Clin Infect Dis 2001;33:2023-7.
25. Wormser GP, Nadelman RB, Dattwyler RJ, Dennis DT, Shapiro ED, Steere AC, et al. Practice guidelines for the treatment of Lyme disease. The Infectious Diseases Society of America. Clin Infect Dis 2000;31(Suppl 1):1-14.
26. Dumler JS. Molecular tools for the diagnosis of Lyme disease: review and meta-analysis. Mol Diagn 2001;6:1-11.
27. Seinost G, Dykhuizen DE, Dattwyler RJ, Golde WT, Dunn JJ, Wang IN, et al. Four clones of Borrelia burgdorferi sensu stricto cause invasive infection in humans. Infect Immun 1999;67:3518-24.
28. Wormser GP, Bittker S, Cooper D, Nowakowski J, Nadelman RB, Pavia C. Yield of large-volume blood cultures in patients with early Lyme disease. J Infect Dis 2001;184:1070-2.
29. Steere AC. Musculoskeletal manifestations of Lyme disease. Am J Med 1995;98:44S-8S.
30. Carlson D, Hernandez J, Bloom BJ, Coburn J, Aversa JM, Steere AC. Lack of Borrelia burgdorferi DNA in synovial samples from patients with antibiotic treatment-resistant Lyme arthritis. Arthritis Rheum 1999;42:2705-9.
31. Sigal LH. Lyme arthritis: lessons learned and to be learned. Arthritis Rheum 1999;42:1809-12.
32. Weinstein A, Britchkov M. Lyme arthritis and post-Lyme disease syndrome. Curr Opin Rheumatol 2002;14:383-7.
33. Persing DH, Rutledge BJ, Rys PN, Podzorski DS, Mitchell PD, Reed KD, et al. Target imbalance: disparity of Borrelia burgdorferi genetic material in synovial fluid from Lyme arthritis patients. J Infect Dis 1994;169:668-72.
34. Coyle PK, Schutzer SE. Neurologic aspects of Lyme disease. Med Clin North Am 2002;86:261-84.
35. Fix AD, Strickland GT, Grant J. Tick bites and Lyme disease in an endemic setting: problematic use of serologic testing and prophylactic antibiotic therapy. JAMA 1998;279:206-10.
36. Halperin JJ. Neuroborreliosis: central nervous system involvement. Semin Neurol 1997;17:19-24.
37. Steere AC, Berardi VP, Weeks KE, Logigian EL, Ackermann R. Evaluation of the intrathecal antibody response to Borrelia burgdorferi as a diagnostic test for Lyme neuroborreliosis. J Infect Dis 1990;161:1203-9.
38. Halperin JJ, Volkman DJ, Wu P. Central nervous system abnormalities in Lyme neuroborreliosis. Neurology 1991;41:1571-82.
39. Tugwell P, Dennis DT, Weinstein A, Wells G, Shea B, Nichol G, et al. Laboratory evaluation in the diagnosis of Lyme disease. Clinical guideline, part 2. Ann Intern Med 1997;127:1109-23.
40. Lebech AM, Hansen K, Brandrup F, Clemmensen O, Halkier-Sorensen L. Diagnostic value of PCR for detection of Borrelia burgdorferi DNA in clinical specimens from patients with erythema migrans and Lyme neuroborreliosis. Mol Diagn 2000;5:139-50.
41. Krüger WH, Pulz M. Detection of Borrelia burgdorferi in cerebrospinal fluid by the polymerase chain reaction. J Med Microbiol 1991;35:98-102.
42. Lebech AM, Hansen K. Detection of Borrelia burgdorferi DNA in urine samples and in cerebrospinal fluid samples from patients with early and late Lyme neuroborreliosis by polymerase chain reaction. J Clin Microbiol 1992;30:1646-53.
43. Amouriaux P, Assous M, Margarita D, Baranton G, Saint Girons I. Polymerase chain reaction with the 30-kb circular plasmid of Borrelia burgdorferi B31 as a target for detection Lyme borreliosis agents in cerebrospinal fluid. Res Microbiol 1993;144:211-9.
44. Huppertz HI, Schmidt H, Karch H. Detection of Borrelia burgdorferi by nest polymerase chain reaction in cerebrospinal fluid and urine of children with neuroborreliosis. Eur J Pediatr 1993;152:414-7.
45. Pachner AR, Delaney E. The polymerase chain reaction in the diagnosis of Lyme neuroborreliosis. Ann Neurol 1993;34:544-50.
46. Zbinden R, Goldenberger D, Lucchini GM, Altwegg M. Comparison of two methods for detecting intrathecal synthesis of Borrelia burgdorferi-specific antibodies and PCR for diagnosis of Lyme neuroborreliosis. J Clin Microbiol 1994;32:1795-8.
47. Christen HJ, Eiffert H, Ohlenbusch A, Hanefeld F. Evaluation of the polymerase chain reaction for the detection of Borrelia burgdorferi in cerebrospinal fluid of children with acute peripheral facial palsy. Eur J Pediatr 1995;154:374-7.
48. Issakainene J, Gnehm HE, Lucchini GM, Zbinden R. Value of clinical symptoms, intrathecal specific antibody production and PCR in CSF in the diagnosis of childhood Lyme neuroborreliosis. Klin Pediatr 1996;208:106-9.
49. Nocton JJ, Bloom BJ, Rutledge BJ, Persing DH, Logigian EL, Schmid CH, et al. Detection of Borrelia burgdorferi DNA by polymerase chain reaction in cerebrospinal fluid in Lyme neuroborreliosis. J Infect Dis 1996;174:623-7.
50. Lebech AM, Hansen K, Rutledge BJ, Kolbert CP, Rys PN, Persing DH. Diagnostic detection and direct genotyping of Borrelia burgdorferi by polymerase chain reactions in cerebrospinal fluid in Lyme neuroborreliosis. Mol Diagn 1998;3:131-41.
51. Tang Y-W, Hibbs JR, Tau KR, Qian Q, Skarhus HA, Smith TF, et al. Effective use of polymerase chain reaction for diagnosis of central nervous system infections. Clin Infect Dis 1999;29:803-6.
52. Maiwald M, Stockinger C, Hassler D, von Knebel Doeberitz M, Sonntag HG. Evaluation of the detection of Borrelia burgdorferi DNA in urine samples by polymerase chain reaction. Infection 1995;23:173-9.
53. Bayer ME, Zhang L, Bayer MH. Borrelia burgdorferi DNA in the urine of treated patients with chronic Lyme disease symptoms. A PCR study of 97 cases. Infection 1996;24:347-53.
54. Mercier G, Burckel A, Lucotte G. Detection of Borrelia burgdorferi DNA by polymerase chain reaction in urine specimens of patients with erythema migrans lesions. Mol Cell Probes 1997;11:89-94.
55. Brettschneider S, Bruckbauer H, Klugbauer N, Hofmann H. Diagnostic value of PCR for detection of Borrelia burgdorferi in skin biopsy and urine samples from patients with skin borreliosis. J Clin Microbiol 1998;36:2658-65.
56. Pleyer U, Priem S, Bergmann L, Burmester G, Hartmann C, Krause A. Detection of Borrelia burgdorferi DNA in urine of patients with ocular Lyme borreliosis. Br J Ophthalmol 2001;85:552-5.
57. Klempner MS, Schmid CH, Hu L, Steere AC, Johnson G, McCloud B, et al. Intralaboratory reliability of serologic and urine testing for Lyme disease. Am J Med 2001;110:217-9.
58. Maeda K, Markowitz N, Hawley RC, Ristic M, Cox D, McDade JE. Human infection with Ehrlichia canis, a leukocytic rickettsia. N Engl J Med 1987;316:853-6.
59. Chen S-M, Dumler JS, Bakken JS, Walker DH. Identification of a granulocytotropic Ehrlichia species as the etiologic agent of human disease. J Clin Microbiol 1994;32:589-95.
60. Buller RS, Arens M, Hmiel SP, Paddock CD, Sumner JW, Rikhisa Y, et al. Ehrlichia ewingii, a newly recognized agent of human ehrlichiosis. N Engl J Med 1999;341:148-55.
61. Dumler JS, Walker DH. Tick-borne ehrlichioses: More of them, higher incidences, and greater clinical diversity. Lancet Infect Dis 2001;0:21-8.
62. Olano JP, Walker DH. Human ehrlichioses. Med Clin North Am 2002;86:375-92.
63. Dumler JS, Barbet AF, Bekker CP, Dasch GA, Palmer GH, Ray SC, et al. Reorganization of genera in the families Rickettsiaceae and Anaplasmataceae in the order Rickettsiales: unification of some species of Ehrlichia with Anaplasma, Cowdria with Ehrlichia and Ehrlichia with Neorickettsia, descriptions of six new species combinations and designation of Ehrlichia equi and "HGE agent" as subjective synonyms of Ehrlichia phagocytophila [published correction appears in Int J System Evol Microbiol 2002;52:5-6]. Int J Syst Evol Microbiol 2001;51:2145-65.
64. Bakken JS, Krueth J, Wilson-Nordskog C, Tilden RL, Asanovich K, Dumler JS. Human granulocytic ehrlichiosis (HGE): epidemiologic, clinical and laboratory characteristics for 41 patients from Minnesota and Wisconsin. JAMA 1996;275:199-205.
65. Horowitz HW, Aguero-Rosenfeld ME, McKenna DF, Holmgren D, Hsieh TC, Varde SA, et al. Clinical and laboratory spectrum of culture-proven human granulocytic ehrlichiosis: comparison with culture-negative cases. Clin Infect Dis 1998;27:1314-7.
66. Standaert SM, Yu T, Scott MA, Childs JE, Paddock CD, Nicholson WL, et al. Primary isolation of Ehrlichia chaffeensis from patients with febrile illnesses: clinical and molecular characteristics. J Infect Dis 2000;181:1082-8.
67. Walker DH. Diagnosing human ehrlichioses: current status and recommendations. ASM News 2000;66:287-91. Available at: http://www.206.64.120.149/asmnews/may00/feature3. Accessed November 4, 2003.
68. Childs JE, Sumner JW, Nicholson WL, Massung RF, Standaert SM, Paddock CD. Outcome of diagnostic tests using samples from patients with culture-proven human monocytic ehrlichiosis: implications for surveillance. J Clin Microbiol 1999;37:2997-3000.
69. Walls JJ, Caturegli P, Bakken JS, Asanovich KM, Dumler JS. Improved sensitivity of PCR for diagnosis of human granulocytic ehrlichiosis using epank1 genes of Ehrlichia phagocytophila-group ehrlichiae. J Clin Microbiol 2000;38:354-6.
70. Fishbein DB, Dawson JE, Robinson LE. Human ehrlichiosis in the United States, 1985 to 1990. Ann Intern Med 1994;120:736-43.
71. Dawson JE, Ewing SA. Susceptibility of dogs to infection with Ehrlichia chaffeensis, the causative agent of human ehrlichiosis. Am J Vet Res 1992;53:1322-7.
72. Dawson JE, Stallknecht DE, Howerth EW, Warner C, Biggie K, Davidson WR, et al. Susceptibility of white-tailed deer (Odocoileus virginianus) to infection with Ehrlichia chaffeensis, the etiologic agent of human ehrlichiosis. J Clin Microbiol 1994;32:2725-8.
73. Gusa AA, Buller RS, Storch GA, Huycke MM, Machado LJ, Slater LN, et al. Identification of a p28 gene in Ehrlichia ewingii: evaluation of gene for use as a target for a species-specific PCR diagnostic assay. J Clin Microbiol 2001;39:3871-6.
74. Carpenter CF, Gandhi TK, Kong LK, Corey GR, Chen SM, Walker DH, et al. The incidence of ehrlichial and rickettsial infection in patients with unexplained fever and recent history of tick bite in central North Carolina. J Infect Dis 1999;180:900-3.
75. Anderson BE, Sumner JW, Dawson JE, Tzianabos T, Greene CR, Olson JG, et al. Detection of the etiologic agent of human ehrlichiosis by polymerase chain reaction. J Clin Microbiol 1992;30:775-80.
76. Everett ED, Evans KA, Henry RB, McDonald G. Human ehrlichiosis in adults after tick exposure. Diagnosis using polymerase chain reaction. Ann Intern Med 1994;120:730-5.
77. Paddock CD, Folk SM, Shore GM, Machado LJ, Huycke MM, Slater LN, et al. Infections with Ehrlichia chaffeensis and Ehrlichia ewingii in persons coinfected with human immunodeficiency virus. Clin Infect Dis 2001;33:1586-94.
78. Sumner JW, Nicholson WL, Massung RF. PCR amplification and comparison of nucleotide sequences from the groESL heat shock operon of Ehrlichia species. J Clin Microbiol 1997;35:2087-92.
79. Yu X-J, Walker DH. Sequence and characterization of an Ehrlichia chaffeensis gene encoding 314 amino acids highly homologous to the NAD A enzyme. FEMS Microbiol Lett 1997;154:53-8.
80. Paddock CD, Sumner JW, Shore GM, Bartley DC, Elie RC, McQuade JG, et al. Isolation and characterization of Ehrlichia chaffeensis strains from patients with fatal ehrlichiosis. J Clin Microbiol 1997;35:2496-502.
81. Sulkowski MS, Dumler JS. The clinical spectrum of disease due to Ehrlichia chaffeensis: report of two cases and review. Infect Dis Clin Prac 1998;7:252-6.
82. Bakken JS, Dumler JS, Chen SM, Eckman MR, Van Etta LL, Walker DH. Human granulocytic ehrlichiosis in the upper midwest United States. A new species emerging? JAMA 1994;272:212-8.
83. Madigan JE, Richter PJ, Kimsey RB, Barlough JE, Bakken JS, Dumler JS. Transmission and passage in horses of the agent of human granulocytic ehrlichiosis. J Infect Dis 1995;172:1141-4.
84. McQuiston JH, Paddock CD, Holman RC, Childs JE. The human ehrlichioses in the United States. Emerg Infect Dis 1999;5:635-42.
85. Bakken JS, Goellner P, Van Etten M, Boyle DZ, Swonger OL, Mattson S, et al. Seroprevalence of human granulocytic ehrlichiosis among permanent residents of northwestern Wisconsin. Clin Infect Dis 1998;27:1491-6.
86. Walker DH, Dumler JS. Human monocytic and granulocytic ehrlichioses. Discovery and diagnosis of emerging tick-borne infections and the critical role of the pathologist. Arch Pathol Lab Med 1997;121:785-91.
87. Aguero-Rosenfeld M, Horowitz HW, Wormser GP, McKenna DF, Nowakowski J, Munoz J, et al. Human granulocytic ehrlichiosis (HGE): a series from a single medical center in New York State. Ann Intern Med 1996;125:904-8.
88. Bakken JS, Aguero-Rosenfeld ME, Tilden RL, Wormser GP, Horowitz HW, Raffalli JT, et al. Serial measurements of hematologic counts during the active phase of human granulocytic ehrlichiosis. Clin Infect Dis 2001;32:862-70.
89. Pusterla N, Leutenegger CM, Chae JS, Lutz H, Kimsey RB, Dumler JS, et al. Quantitative evaluation of ehrlichial burden in horses after experimental transmission of human granulocytic Ehrlichia agent by intravenous inoculation with infected leukocytes and by infected ticks. J Clin Microbiol 1999;37:4042-4.
90. Pusterla N, Madigan JE, Asanovich KM, Chae JS, Derock E, Leutenegger CM, et al. Experimental inoculation with human granulocytic Ehrlichia agent derived from high-and low-passage cell culture in horses. J Clin Microbiol 2000;38:1276-8.
91. Edelman DC, Dumler JS. Evaluation of an improved PCR diagnostic assay for human granulocytic ehrlichiosis. Mol Diagn 1996;1:41-9.
92. IJdo JW, Meek JI, Cartter ML, Magnarelli LA, Wu C, Tenuta SW, et al. The emergence of another tickborne infection in the 12-town area around Lyme, Connecticut: human granulocytic ehrlichiosis. J Infect Dis 2000;181:1388-93.
93. Horowitz HW, Aguero-Rosenfeld M, Dumler JS, McKenna DF, Hsieh TC, Wu J, et al. Reinfection with the agent of human granulocytic ehrlichiosis. Ann Intern Med 1998;129:461-3.
94. Goodman JL, Nelson C, Vitale B, Madigan JE, Dumler JS, Kurtti TJ, et al. Direct cultivation of the causative agent from patients with human granulocytic ehrlichiosis. N Engl J Med 1996;334:209-15.
95. Murphy CI, Storey JR, Recchia J, Doros-Richert LA, Gingrich-Baker C, Munroe K, et al. Major antigenic proteins of the agent of human granulocytic ehrlichiosis are encoded by members of a multigene family. Infect Immun 1998;66:3711-8.
96. IJdo JW, Sun W, Zhang Y, Magnarelli LA, Fikrig E. Cloning of the gene encoding the 44-kilodalton antigen of the agent of human granulocytic ehrlichiosis and characterization of the humoral response. Infect Immun 1998;66:3264-9.
97. Caturegli P, Asanovich KM, Walls JJ, Bakken JS, Madigan JE, Popov VL, et al. ank A: an Ehrlichia phagocytophila group gene encoding a cytoplasmic protein antigen with ankyrin repeats. Infect Immun 2000;68:5277-83.
98. Caspersen K, Park JH, Patil S, Dumler JS. Genetic variability and stability of Anaplasma phagocytophila msp2 (p44). Infect Immun 2002;70:1230-4.
99. Zhi N, Ohashi N, Rikihisa Y, Horowitz HW, Wormser GP, Hechemy K. Cloning and expression of the 44-kilodalton major outer membrane protein gene of the human granulocytic ehrlichiosis agent and application of the recombinant protein to serodiagnosis. J Clin Microbiol 1998;36:1666-73.
100. Storey JR, Doros-Richert LA, Gingrich-Baker C, Munroe K, Mather TN, Coughlin RT, et al. Molecular cloning and sequencing of three granulocytic Ehrlichia genes encoding high-molecular weight immunoreactive proteins. Infect Immun 1998;66:1356-63.
101. Anziani OS, Ewing SA, Barker RW. Experimental transmission of a granulocytic form of the tribe Ehrlichieae by Dermacentor variabilis and Amblyomma americanum to dogs. Am J Vet Res 1990;51:929-31.
102. Yabsley MJ, Varela AS, Tate CM, Dugan VG, Stallknecht DE, Little SE, et al. Ehrlichia ewingii infection in white-tailed deer (Odocoileus virginianus). Emerg Infect Dis 2002;8:668-71.
103. Goldman EE, Breitschwerdt EB, Grindem CB, Hegarty BC, Walls JJ, Dumler JS. Granulocytic ehrlichiosis in dogs from North Carolina and Virginia. J Vet Intern Med 1998;12:61-70.
104. Murphy GL, Ewing SA, Whitworth LC, Fox JC, Kocan AA. A molecular and serologic survey of Ehrlichia canis, E chaffeensis, and E ewingii in dogs and ticks from Oklahoma. Vet Parasitol 1998;79:325-39.